Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Selling, general and administrative

Research and development

Litigation settlement gain

Restructuring and other charges

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Align Technology

Align Technology, Inc. engages in the design, manufacture, and market of orthodontics, restorative, and aesthetic dentistry products. It operates through the Clear Aligner, and Scanner and Services segments. The Clear Aligner segment consists of Invisalign full, teen, and assist products, and Vivera retainers for treating malocclusion. The Scanner and Services segment consists of intraoral scanning systems such as single hardware platforms and restorative or orthodontic software options, ancillary products, and other related additional services. The company was founded by Zia Chishti, Brian Freyburger, and Kelsey Wirth in March 1997 and is headquartered in Tempe, AZ.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Align Technology reports Q4 growth, eyes tech advancements for 2023

Align Technology's Q4 performance showed revenue growth in Systems and Services but challenges in Clear Aligner volumes, particularly in China.
The company is focusing on technology advancements, digital subscriptions, and margin improvement for 2023.
Investments in R&D for digital orthodontics and subscription programs present opportunities for future growth.
Despite challenges in China, Align remains optimistic about stability and growth in other regions.

Align Technology beats Q1 revenue expectations, eyes Q2 growth

Align Technology's Q1 performance exceeded expectations with revenue growth.
Stable Clear Aligner business and focus on teen market are strengths.
Challenges include increased expenses and uncertainty in margins.
Opportunities lie in expected volume and ASP increases in Q2.

Align Technology surpasses Q2 expectations, eyes international growth opportunities

Align Technology delivered strong Q2 results, driven by revenue growth in Clear Aligner and Systems and Services segments, with a focus on innovation and strategic initiatives.
The company's performance in international markets, particularly EMEA and APAC, showcased significant growth in teen cases and adoption of the DSP program.
While facing challenges in the teen market and competitive landscape, Align Technology remains optimistic about its long-term growth prospects and market positioning.
Opportunities for Align include continued innovation, market expansion, and investor engagement through strategic initiatives and product differentiation.

Align Technology reports Q3 revenue growth amidst macro challenges

Align Technology navigated challenges in Q3 with revenue growth driven by clear aligner shipments to younger patients and increased services revenue.
Despite lower Q3 demand, the company remains optimistic for 2024 revenue growth through new technologies and digital orthodontics adoption.
Strategic investments in R&D, cost management, and consumer advertising position Align Technology for future growth and margin improvement.

Align Technology surpasses Q4 expectations, eyes innovation for growth

Align Technology delivered strong financial performance in Q4 2023, with robust revenue growth and effective cost management.
The company's focus on innovation, strategic partnerships, and market expansion positions it well for future growth.
While facing challenges such as regulatory approvals and cash flow fluctuations, Align Technology has opportunities in market expansion and cost-saving initiatives.
Overall, Align Technology's performance, strengths, and strategic outlook indicate a positive trajectory for sustainable growth and profitability.

Align Technology posts solid Q1 earnings, eyes growth opportunities

Align Technology's Q1 performance reflects revenue growth and strategic investments in innovation and market expansion.
While facing challenges in operating expenses and margin decline, the company's strengths lie in product innovation and brand visibility.
Opportunities in new market expansion, targeting younger patients, and operational investments set the stage for future growth and profitability.

Align Technology posts solid Q2 results, eyes market expansion

Align Technology delivered strong financial performance in Q2, driven by revenue growth, margin expansion, and increasing adoption of its innovative solutions.
The company's focus on product innovation, digital tools, and marketing initiatives has bolstered its market position and customer engagement.
While facing challenges in a competitive landscape and regulatory processes, Align Technology remains well-positioned to capitalize on opportunities in the orthodontic market.
Strategic initiatives to drive growth, enhance operational efficiency, and expand market reach are key priorities for sustaining momentum and profitability.

Align Technology reports mixed Q3 results, eyes international growth

Align Technology's Q3 '24 showcased mixed results but highlighted growth opportunities in international markets and new product innovations.
Despite challenges in the U.S. market, the company's strategic focus on operational efficiency and digital innovation positions it for future success.
Investments in expansion and supporting doctor customers signal a commitment to driving growth and profitability in the long term.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Facebook Frowns, Align Smiles as Another Earnings-Packed Day Leaves Stock Markets Mixed

Shares of Align Tech (NASDAQ:ALGN) decreased 0.1% in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share increased 968.57% over the past year to $3.04, which beat the estimate of $2.55.

Align Tech: Q2 Earnings Insights

TEMPE, Ariz., July 28, 2021 (GLOBE NEWSWIRE) -- Align Technology, Inc. (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign system of clear aligners, iTero intraoral scanners, and exocad CAD/CAM software for digital orthodontics and restorative dentistry, today reported financial results for the second quarter of fiscal 2021 ("Q2'21"). Q2'21 total revenues were $1.0 billion, up 13.0% sequentially and 186.9% year-over-year. Q2'21 Clear Aligner revenues were $841.0 million, up 11.6% sequentially and 181.9% year-over-year. Q2'21 Imaging Systems and CAD/CAM Services revenues were $169.8 million, up 20.0% sequentially and 214.7% year-over-year. Q2'21 Clear Aligner volume was 665.6 thousand cases, up 11.7% sequentially and 200.0% year-over-year. For the Americas, Q2'21 Clear Aligner volume was up 10.9% sequentially and 260.7% year-over-year. For International regions, Q2'21 Clear Aligner volume was up 12.7% sequentially and 149.2% year-over-year. Q2'21 Clear Aligner volume for teens was 181.0 thousand cases, up 9.5% sequentially and 156.3% year-over-year. Q2'21 operating income was $268.9 million, resulting in an operating margin of 26.6%. Q2'21 net income was $199.7 million, or $2.51 per diluted share. On a non-GAAP basis, Q2'21 net income was $242.1 million, or $3.04 per diluted share.

Align Technology Announces Record Second Quarter 2021 Financial Results and $1 Billion in Quarterly Revenues for First Time

Align Technology (ALGN) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Why Align Technology (ALGN) Might Surprise This Earnings Season

Retractable Technologies

STAAR Surgical

Their business models are timeless, and their revenue is rising.

3 Value Stocks That Won't Stop Growing

Align Technology (ALGN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Why Align Technology (ALGN) Could Beat Earnings Estimates Again

Shopify

Here are two strong growth-focused stocks poised to thrive for years that investors might want to consider buying around their Q2 earnings reports.

Buy These 2 Growth Stocks Before Earnings and Hold for Years?

TEMPE, Ariz. and PETACH TIKVA, Israel, July 21, 2021 (GLOBE NEWSWIRE) -- Align Technology, Inc. (“Align”) (Nasdaq: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign system of clear aligners, iTero intraoral scanners, and exocad CAD/CAM software for digital orthodontics and restorative dentistry, today announced that it has opened its new facilities atop one of the three high-rise buildings that make up the "Global Towers" in Petach Tikva, Israel. The Company will relocate employees from its current location in Or Yehuda. The move follows the purchase of the top nine floors of the building for $51.4 million, as previously disclosed in Align's Form 10-Q for the first quarter ended March 30, 2020.

Align Technology Expands Presence in Israel With New Facilities to Support iTero Scanner and Services Global Operations and Long Term Growth

Align to reinforce its commitment to comprehensive dentistry by showcasing the Align Digital Platform, including recent innovations, in a multi-media exhibition space of hybrid in-person and virtual experiences Align to reinforce its commitment to comprehensive dentistry by showcasing the Align Digital Platform, including recent innovations, in a multi-media exhibition space of hybrid in-person and virtual experiences

Align Technology to Showcase Its Digital Portfolio at the International Dental Show 2021 in Cologne

Disney

Etsy

If your kids' immediate needs are covered, these stocks could help build a nest egg for their future.

3 Great Stocks to Buy for Your Kids With Your Child Tax Credit

The shares of Align Technology, Inc. (NASDAQ: ALGN) have received a price target increase from $600 to $700 from Stephens. These are the details.

ALGN Stock: $700 Target From Stephens

Strong performance and latest innovations in the Invisalign and iTero family are driving the top line for Align Technology (ALGN).

What Makes Align Technology (ALGN) a Solid Choice Right Now?

Is (ALGN) Outperforming Other Medical Stocks This Year?

Has Align Technology (ALGN) Outpaced Other Medical Stocks This Year?

Henry Schein

Patterson Companies

DENTSPLY SIRONA

Dental stocks like Henry Schein (HSIC), Align Technology (ALGN), Straumann Holding (SAUHF) and DENTSPLY SIRONA (XRAY) are expected to continue their run over the next few months.

Dental Space Gains Momentum in 2021: 4 Stocks to Invest in

Does Align Technology (ALGN) have what it takes to be a top stock pick for momentum investors? Let's find out.

Align Technology (ALGN) Is Up 2.22% in One Week: What You Should Know

TEMPE, Ariz., July 01, 2021 (GLOBE NEWSWIRE) -- Align Technology, Inc. (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign system of clear aligners, iTero intraoral scanners, and exocad CAD/CAM software for digital orthodontics and restorative dentistry, announced today that the Company will report second quarter 2021 financial results on Wednesday, July 28, 2021, after the close of market. Financial results will be released at 4:00 p.m. ET (1:00 p.m. PT) and will be available on the Investor Relations section of the Company's website at http://investor.aligntech.com.

Align Technology to Announce Second Quarter 2021 Results on July 28, 2021

100 Young Leaders to Receive $5,000 Each to Support their Community Projects 100 Young Leaders to Receive $5,000 Each to Support their Community Projects

Align Technology Announces Recipients of Its Invisalign® ChangeMakers Program

Applied Materials

Array Technologies

Baidu

Paya Holdings

Uber

Western Digital

Billionaire Steve Cohen is one of the best investors ever. And here are seven of his top picks that are great stocks to buy.

Top 7 Stocks To Buy if You Want To Channel Billionaire Steve Cohen

Align (ALGN) partners with a popular social media star to release a limited-edition case for Invisalign aligners.

Align (ALGN) to Launch Limited-Edition Invisalign Aligner Case

Social Media Star Charli D'Amelio Partners with Align Technology's Invisalign Brand to Transform More Smiles with its First Limited-Edition Product Social Media Star Charli D'Amelio Partners with Align Technology's Invisalign Brand to Transform More Smiles with its First Limited-Edition Product

All Smiles Here: Align Technology Introduces the Limited-Edition Charli D'Amelio x Invisalign® Aligner Case

Align Technology (ALGN) closed at $601.64 in the latest trading session, marking a -1.91% move from the prior day.

Align Technology (ALGN) Dips More Than Broader Markets: What You Should Know

TEMPE, Ariz., June 17, 2021 (GLOBE NEWSWIRE) -- Align Technology, Inc. (“Align”) (Nasdaq: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign system of clear aligners, iTero intraoral scanners, and exocad CAD/CAM software for digital orthodontics and restorative dentistry, today announced that the Align Foundation, the Company's donor-advised fund through Fidelity Charitable, has donated US$1 million to Operation Smile, a global surgical nonprofit, to help children around the world born with cleft conditions receive safe, effective, and timely cleft surgery and comprehensive care.

Align Technology Honors 10 Million Invisalign Smiles Milestone With US$1 Million to Operation Smile for Children Born With Cleft Lip And Cleft Palate

When a stock breaks out above the 50-Day simple moving average, good things could be on the horizon. How should investors react?

Align Technology (ALGN) Crossed Above the 50-Day Moving Average: What That Means for Investors

Good things could be on the horizon when a stock surpasses the 20-day simple moving average. How should investors react?

Align Technology (ALGN) Just Reclaimed the 20-Day Moving Average

Align Technology's (ALGN) iTero Workflow 2.0 software and iTero Element 5D Imaging system auto-upload functionality to drive innovation in digital orthodontics and restorative dentistry.

News for Align Technology Stock (ALGN)